Older Drugs With Limited Trial Evidence: Are They Worth the Expense?

Daniel M. Hartung, David M. Cohen, Atul Deodhar, Dennis N. Bourdette

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Older Drugs With Limited Trial Evidence: Are They Worth the Expense?'. Together they form a unique fingerprint.